13 Apr 2018 - Perth-based clinical trials company Zelda Therapeutics (ASX:ZLD) now has approval for their autism project involving cannabis to be conducted at the USA-based Children’s Hospital of Philadelphia.
This exclusive 48-hour opportunity is available only to DealRoom members.
Sign up now to access the deal - and get early access to future offerings.
216 views
SUMMARY
13 Apr 2018 - Perth-based clinical trials company Zelda Therapeutics (ASX:ZLD) now has approval for their autism project involving cannabis to be conducted at the USA-based Children’s Hospital of Philadelphia.
POST YOUR COMMENT
COMMENTS